Journal of Applied Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 89: 629-635, 2000;
8750-7587/00 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weltman, A.
Right arrow Articles by Veldhuis, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weltman, A.
Right arrow Articles by Veldhuis, J. D.
Vol. 89, Issue 2, 629-635, August 2000

Exercise-dependent growth hormone release is linked to markers of heightened central adrenergic outflow

Arthur Weltman1,2, Cathy J. Pritzlaff1, Laurie Wideman2, Judy Y. Weltman2, Jeffery L. Blumer3, Robert D. Abbott4, Mark L. Hartman2, and Johannes D. Veldhuis2

Departments of 1 Human Services, 2 Medicine, and 4 Health Evaluation Sciences, University of Virginia, Charlottesville, Virginia 22903; and 3 Department of Pediatrics and Pharmacology, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland Ohio 44106

To test the hypothesis that heightened sympathetic outflow precedes and predicts the magnitude of the growth hormone (GH) response to acute exercise (Ex), we studied 10 men [age 26.1 ± 1.7 (SE) yr] six times in randomly assigned order (control and 5 Ex intensities). During exercise, subjects exercised for 30 min (0900-0930) on each occasion at a single intensity: 25 and 75% of the difference between lactate threshold (LT) and rest (0.25LT, 0.75LT), at LT, and at 25 and 75% of the difference between LT and peak (1.25LT, 1.75LT). Mean values for peak plasma epinephrine (Epi), plasma norepinephrine (NE), and serum GH concentrations were determined [Epi: 328 ± 93 (SE), 513 ± 76, 584 ± 109, 660 ± 72, and 2,614 ± 579 pmol/l; NE: 2.3 ± 0.2, 3.9 ± 0.4, 6.9 ± 1.0, 10.7 ± 1.6, and 23.9 ± 3.9 nmol/l; GH: 3.6 ± 1.5, 6.6 ± 2.0, 7.0 ± 2.0, 10.7 ± 2.4, and 13.7 ± 2.2 µg/l for 0.25, 0.75, 1.0, 1.25, and 1.75LT, respectively]. In all instances, the time of peak plasma Epi and NE preceded peak GH release. Plasma concentrations of Epi and NE always peaked at 20 min after the onset of Ex, whereas times to peak for GH were 54 ± 6 (SE), 44 ± 5, 38 ± 4, 38 ± 4, and 37 ± 2 min after the onset of Ex for 0.25-1.75LT, respectively. ANOVA revealed that intensity of exercise did not affect the foregoing time delay between peak NE or Epi and peak GH (range 17-24 min), with the exception of 0.25LT (P < 0.05). Within-subject linear regression analysis disclosed that, with increasing exercise intensity, change in (Delta ) GH was proportionate to both Delta NE (P = 0.002) and Delta Epi (P = 0.014). Furthermore, within-subject multiple-regression analysis indicated that the significant GH increment associated with an antecedent rise in NE (P = 0.02) could not be explained by changes in Epi alone (P = 0.77). Our results suggest that exercise intensity and GH release in the human may be coupled mechanistically by central adrenergic activation.

catecholamines; epinephrine; norepinephrine


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
J. R. Pierce, B. C. Clark, L. L. Ploutz-Snyder, and J. A. Kanaley
Growth hormone and muscle function responses to skeletal muscle ischemia
J Appl Physiol, December 1, 2006; 101(6): 1588 - 1595.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. Wideman, L. Consitt, J. Patrie, B. Swearingin, R. Bloomer, P. Davis, and A. Weltman
The impact of sex and exercise duration on growth hormone secretion
J Appl Physiol, December 1, 2006; 101(6): 1641 - 1647.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. R. Collier, E. Collins, and J. A. Kanaley
Oral arginine attenuates the growth hormone response to resistance exercise
J Appl Physiol, September 1, 2006; 101(3): 848 - 852.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, J. T. Patrie, K. T. Brill, J. Y. Weltman, E. E. Mueller, C. Y. Bowers, and A. Weltman
Contributions of Gender and Systemic Estradiol and Testosterone Concentrations to Maximal Secretagogue Drive of Burst-Like Growth Hormone Secretion in Healthy Middle-Aged and Older Adults
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6291 - 6296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Wideman, J. Y. Weltman, J. T. Patrie, C. Y. Bowers, N. Shah, S. Story, J. D. Veldhuis, and A. Weltman
Synergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exercise
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1467 - R1477.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online